Lizhen F. Wang
National Health Commission Key Laboratory Of Nuclear Medicine, Jiangsu Key Laboratory Of Molecular Nuclear Medicine
Wuxi, 214063, China
Wuxi, 214063, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Soluble-Antigen-Based PET/MR for the Specific Detection of BCMA CAR+ T-Cell Lymphoma.
Journal: Molecular pharmaceutics
Published: May 28, 2026
The Critical Dosing Interval in Oncology Pretargeted Radionuclide Imaging and Therapy: Mechanisms, Optimization, and Dosimetric Impact.
Journal: Bioconjugate chemistry
Published: May 14, 2026
Development and Preclinical Evaluation of a Selinexor-Derived Radiotracer [68Ga]Ga-NOTA-Selinexor for Imaging XPO1 Expression in Multiple Myeloma.
Journal: Molecular pharmaceutics
Published: April 02, 2026
Relationship between childhood trauma and depressive symptoms in adolescents with major depressive episodes and the mediating roles of perceived stress and abnormal brain structural development
Journal: Zhonghua yi xue za zhi
Published: February 05, 2026
Specific PET Imaging for Precision Management of Lung Cancer: Advances, Clinical Translation and Future Directions.
Journal: Chemical & biomedical imaging
Published: December 29, 2025
Fluorobenzylation promotes immune-activating peptides to turn cold tumors into hot tumors.
Journal: Materials horizons
Published: October 01, 2025
Exploring 18F/19F Isotopic Exchange for the Synthesis of [18F]Trifluoromethylated Arenes.
Journal: Bioconjugate chemistry
Published: August 08, 2025
Structure-guided olaparib PET probe enables enhanced PARP-1 precision imaging.
Journal: Bioorganic chemistry
Published: August 04, 2025
Radiosynthesis and PET evaluation of [18F]Fuzuloparib as a PARP-targeted imaging agent in breast cancer.
Journal: European journal of medicinal chemistry
Published: June 19, 2025
Development and evaluation of a 99mTc-labeled olaparib analog for PARP imaging.
Journal: EJNMMI radiopharmacy and chemistry
Published: May 13, 2025
Bioorthogonal liposome-based sequential drug delivery system for enhanced tumor accumulation and targeted therapy.
Journal: Drug delivery and translational research
Published: April 08, 2025
Last Updated: 09/26/2026